bpc-157 clinical trials humans bpc 157 human gut trial safety data is being marketed as a “ BPC-157 - Wikipedia

CagriSema is a combination of cagrilintide and semaglutide, which leverages the benefits of both a long-acting amylin analog and a GLP-1 receptor agonist to enhance weight loss, potentially offering a dual mechanism of action that current treatments don't provide

Selank has a nootropic action, which positively influences the formation of memory and learning processes

Stem cells and exosomes may protect neuron function by many mechanisms including releasing neurotrophic growth factors, regulating glial cell activity, enhancing BDNF activity, shutting off neuroinflammatory signals, controling cell turnover and cell death, downregulating formation of plaque, gliosis, and scar, and upregulating microRNA expression signals for neural repair (13) (14) (15) (16) (17) (18)

A tiny catheter is placed through the artery in the groin (called the femoral artery) and directed under x-ray vision to the prostate artery, so that small particles can be placed into the prostate artery to decrease the blood supply to the prostate